Annual Cash & Cash Equivalents
$9.13B$2.84B-23.75%
Summary
- Current Value
- As of today, AMGN annual cash & cash equivalents is $9.13B, down -23.75% on
- Historical Performance
- AMGN annual cash & cash equivalents is down -1.89% over the past 3 years, down -14.26% over the past 5 years
- All-Time High Comparison
- AMGN annual cash & cash equivalents is currently -78.10% below its historical high of $41.68B set on
- 3-Year Low Comparison
- AMGN annual cash & cash equivalents is at its 3-year low
- Sector Comparison
- AMGN annual cash & cash equivalents is higher than 98.85% of companies in Healthcare sector
Cash and Cash Equivalents Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $9.13B | -23.8% | -1.9% | -14.3% | -47.6% | |
| Quarterly Cash & Cash Equivalents | $13.19B | +39.6% | -62.0% | +2.1% | -25.4% | |
| Price | $439.59 | +28.4% | +65.6% | +113.3% | +691.0% | |
| Annual Current Assets | $29.06B | +0.1% | +31.0% | +37.4% | +25.6% | |
| Annual Total Liabilities | $81.93B | -4.7% | +33.3% | +53.0% | +319.2% | |
| Annual Working Capital | $3.57B | -39.8% | -45.1% | -62.4% | -78.5% | |
| Annual Net Income | $7.71B | +88.5% | +17.7% | +6.2% | +66.7% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $11.97B | -23.8% | |
| 5Y | $11.97B | -23.8% | |
| All | $41.68B | -78.1% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $9.13B | at low | |
| 5Y | $8.04B | +13.6% | |
| All | $20.70M | >+9999.0% |
Cash and Cash Equivalents History
FAQ
- What is the current annual cash & cash equivalents of AMGN?
- As of today, AMGN annual cash & cash equivalents is $9.13B
- What is 1-year change in AMGN annual cash & cash equivalents?
- AMGN annual cash & cash equivalents is down -23.75% year-over-year
- What is 3-year change in AMGN annual cash & cash equivalents?
- AMGN annual cash & cash equivalents is down -1.89% over the past 3 years
- How far is AMGN annual cash & cash equivalents from its all-time high?
- AMGN annual cash & cash equivalents is currently -78.10% below its historical high of $41.68B set on December 31, 2017
- How does AMGN annual cash & cash equivalents rank versus sector peers?
- AMGN annual cash & cash equivalents is higher than 98.85% of companies in Healthcare sector
- When is AMGN next annual earnings release?
- The next annual earnings release for AMGN is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Quarterly Cash & Cash Equivalents
$13.19B$799.00M-5.71%
Summary
- Current Value
- As of today, AMGN quarterly cash & cash equivalents is $13.19B, down -5.71% on
- Historical Performance
- AMGN quarterly cash & cash equivalents is up +39.65% year-over-year, down -62.03% over the past 3 years
- All-Time High Comparison
- AMGN quarterly cash & cash equivalents is currently -68.35% below its historical high of $41.68B set on
- 3-Year Low Comparison
- AMGN quarterly cash & cash equivalents is +64.30% above its 3-year low of $8.03B reached on
- Sector Comparison
- AMGN quarterly cash & cash equivalents is higher than 99.46% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $13.19B | -5.7% | +39.6% | -62.0% | +2.1% | |
| Annual Cash & Cash Equivalents | $9.13B | – | -23.8% | -1.9% | -14.3% | |
| Price | $439.59 | -0.6% | +28.4% | +65.6% | +113.3% | |
| Quarterly Current Assets | $34.36B | -1.7% | +23.2% | -29.1% | +41.0% | |
| Quarterly Total Liabilities | $81.70B | -2.7% | +1.5% | -1.4% | +43.9% | |
| Quarterly Working Capital | $11.13B | +17.7% | +82.7% | -64.7% | +16.7% | |
| Quarterly Net Income | $3.86B | +62.7% | +20.1% | +123.3% | +105.1% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $13.99B | -5.7% | |
| 3Y | $34.74B | N/A | -62.0% |
| 5Y | $34.74B | -62.0% | |
| All | $41.68B | -68.3% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $9.13B | +44.5% | |
| 3Y | $8.03B | +64.3% | |
| 5Y | $6.54B | +101.6% | |
| All | $13.20M | >+9999.0% |
Quarterly Cash & Cash Equivalents History
FAQ
- What is the current quarterly cash & cash equivalents of AMGN?
- As of today, AMGN quarterly cash & cash equivalents is $13.19B
- What is AMGN quarterly cash & cash equivalents most recent change?
- AMGN quarterly cash & cash equivalents was down -5.71% on September 30, 2026
- What is 1-year change in AMGN quarterly cash & cash equivalents?
- AMGN quarterly cash & cash equivalents is up +39.65% year-over-year
- How far is AMGN quarterly cash & cash equivalents from its all-time high?
- AMGN quarterly cash & cash equivalents is currently -68.35% below its historical high of $41.68B set on December 31, 2017
- How does AMGN quarterly cash & cash equivalents rank versus sector peers?
- AMGN quarterly cash & cash equivalents is higher than 99.46% of companies in Healthcare sector
- When is AMGN next earnings release?
- The next earnings release for AMGN is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- AMGN Official Website www.amgen.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/318154/000031815426000003/0000318154-26-000003-index.htm
- AMGN Profile on Yahoo Finance finance.yahoo.com/quote/AMGN
- AMGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/amgn
